Tender Details

Country: Poland
Summary: Successive Delivery of the Medicinal Product Containing the Active Substance Nivolumab Along with the Labeling, Release and Transport Process to 8 Centers in Poland
PLT Ref No: 71156081
Deadline: 15 Sep 2022
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 477493-2022
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
The subject of the contract is the successive delivery of a medicinal product containing the active substance nivolumab along with the process of labeling, releasing and transporting the drug to 8 centers as part of a non-commercial clinical trial: "The use of nivolumab (N) fromwith tarsal chemotherapy: bendamustine, gemcitabine and dexamethasone (BGD) with autologous bone marrow transplantation in patients with 1-line refractory Hodgkin's lymphoma "(" Nivolumab followed by bendamustine, gemcitabine and dexamethasone chemotherapy (BGD) and autologous hematlaopontation in patients refractory to first line treatment ") - 2020 / ABM / 01/00103 as part of the Medical Research Agency (ABM) competition for research and development in the field of non-commercial clinical trials. The Medical University of Gdańsk acts as the sponsor of a non-commercial clinical trial (in accordance withGood Clinical Practice (GCP).
Doc Title: Pharmaceutical products
Contract Type: Supplies
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Successive Delivery of the Medicinal Product Containing the Active Substance Nivolumab Along with the Labeling, Release and Transport Process to 8 Centers in Poland - Poland Tender

The MEDICAL UNIVERSITY OF GDAŃSK, a Government sector organization in Poland, has announced a new tender for Successive Delivery of the Medicinal Product Containing the Active Substance Nivolumab Along with the Labeling, Release and Transport Process to 8 Centers in Poland. This tender is published on PolandTenders under PLT Ref No: 71156081 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-09-15.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.